BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16523396)

  • 21. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of therapeutic effect of catergen in viral hepatitis].
    Boroń P; Boroń-Kaczmarska A; Sokolewicz-Bobrowska E; Szpakowicz T; Nadowska K
    Pol Tyg Lek; 1979 Aug; 34(33):1315-7. PubMed ID: 117435
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
    Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
    Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
    Shakya N; Vedi S; Liang C; Agrawal B; Tyrrell DL; Kumar R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6475-80. PubMed ID: 22985854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International society for antiviral research - 22nd international conference. Part 1.
    Walker K
    IDrugs; 2009 Jul; 12(7):409-10. PubMed ID: 19579156
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interferon].
    Tamori A; Kawada N
    Nihon Rinsho; 2012 Apr; 70(4):620-4. PubMed ID: 22568143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in hepatitis C therapy during 2000-2002.
    Poordad FF; Tran T; Martin P
    Expert Opin Emerg Drugs; 2003 May; 8(1):9-25. PubMed ID: 14610908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.
    Gentile I; Zappulo E; Buonomo AR; Borgia G
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):775-82. PubMed ID: 24840817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rx for B and C.
    Gibbs WW
    Sci Am; 1999 Mar; 280(3):17-20. PubMed ID: 10048231
    [No Abstract]   [Full Text] [Related]  

  • 31. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Marcellin P
    Liver Int; 2016 Jan; 36 Suppl 1():5-6. PubMed ID: 26725890
    [No Abstract]   [Full Text] [Related]  

  • 32. Viral hepatitis in 2011: a major step forward.
    Marcellin P
    Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 34. [The combination administration of interferon in viral hepatitis].
    Zhao GD; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of interferon in the treatment of viral hepatitis and its perspective].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HVB and HVC infections in nephrology].
    Pol S
    Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
    [No Abstract]   [Full Text] [Related]  

  • 39. [Review of recent research on hepatitis C therapy for 54th annual meeting of the American association for the study of liver diseases].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):118-20. PubMed ID: 14980127
    [No Abstract]   [Full Text] [Related]  

  • 40. [When and how to treat hepatitis B and C?].
    Pache I; Hess J; Gonvers JJ; Moradpour D
    Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.